Passive meets aggressive in Teva-Mylan talks - MarketWatch
TEVA Gears Up to Report Q4 Earnings: What's in the Cards?
Israel stocks up; FTC eyes Teva-Cephalon deal - MarketWatch
Israel stocks up, led by Teva, Bezeq - MarketWatch
Israel stocks rise, led by Teva, ICL - MarketWatch
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva Pharmaceuticals - Wikipedia
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Israel stocks tick lower; Teva, Itamar in focus - MarketWatch
Is TEVA Stock A Buy or Sell?
Mylan and Teva stocks rise on report about Amazon's pharmacy aims - MarketWatch
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Teva Pharmaceutical Is in Recovery - WSJ
Hedge Funds Are Dipping Their Toes Into Teva Pharmaceutical Industries (TEVA )
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva Pharmaceutical Industries (NYSE:TEVA) Issues Quarterly Earnings Results - Opera News
Shares of generic drugmakers rise on hope that legal issues are nearing an end - MarketWatch
Teva Stock Climbs as CEO Says Opioid Settlement Could Come Within a Year | Barron's
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Teva Pharmaceutical Industries Stock Is Believed To Be Modestly Undervalued
Israel stocks rise as investors key on Teva, ICL - MarketWatch
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
